Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 09-Jul-2021
No. of pages: 108
Inquire Before Buying

Non-invasive diagnosis is a procedure of identifying a disease without or with minimal incision of the body. These methods involve different techniques such as identifying genetic structure, biomarkers, changes in molecular biology, along with imaging technologies. Cancer is a disease related to genetic alteration of the cells and therefore causing uncontrolled growth and forming tumor like structure. Imaging is the preferred method of cancer detection but cannot have genetic access; on the other hand biopsies which have genetic access are complicated and difficult to perform repetitively during the course of cancer diagnosis and therapy. Therefore newer techniques developed in lines with non invasive diagnosis such as molecular diagnosis, serum based immunoassays and chemical tests to identify chemical components in the body especially from blood and urine. All these procedures are performed either with non-surgical or minimal surgical procedures; therefore these non-invasive cancer diagnostic techniques are becoming more and more popular among healthcare practitioners.

Market Analysis and Insights: Global Noninvasive Cancer Diagnostics Market

The global Noninvasive Cancer Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Noninvasive Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Noninvasive Cancer Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Noninvasive Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Noninvasive Cancer Diagnostics market.

Global Noninvasive Cancer Diagnostics Scope and Market Size

Noninvasive Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Noninvasive Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Clinical Chemistry

- Immunochemistry/Immunoassay

- Molecular Diagnostics

- Others

Segment by Application

- Solid Tumors

- Blood Cancer

- Lung Cancer

- Breast Cancer

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Precision Therapeutics, Inc. (U.S.)

- A&G Pharmaceutical, Inc. (U.S.)

- Affymetrix Inc. (U.S.)

- AVIVA Biosciences Corporation (U.S.)

- BIOVIEW Inc. (U.S.)

- Laboratory Corporation of America Holdings (LabCorp) (U.S.)

- Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)

- Digene Corporation (U.S.)

- Gen-Probe Incorporated (U.S.)

- IVDiagnostics, Inc. (U.S.)

Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Clinical Chemistry
1.2.3 Immunochemistry/Immunoassay
1.2.4 Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Noninvasive Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood Cancer
1.3.4 Lung Cancer
1.3.5 Breast Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Noninvasive Cancer Diagnostics Market Perspective (2016-2027)
2.2 Noninvasive Cancer Diagnostics Growth Trends by Regions
2.2.1 Noninvasive Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Noninvasive Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Noninvasive Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Noninvasive Cancer Diagnostics Industry Dynamic
2.3.1 Noninvasive Cancer Diagnostics Market Trends
2.3.2 Noninvasive Cancer Diagnostics Market Drivers
2.3.3 Noninvasive Cancer Diagnostics Market Challenges
2.3.4 Noninvasive Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Cancer Diagnostics Players by Revenue
3.1.1 Global Top Noninvasive Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Noninvasive Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Noninvasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Noninvasive Cancer Diagnostics Revenue
3.4 Global Noninvasive Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Noninvasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Cancer Diagnostics Revenue in 2020
3.5 Noninvasive Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Noninvasive Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Noninvasive Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Noninvasive Cancer Diagnostics Breakdown Data by Type
4.1 Global Noninvasive Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Noninvasive Cancer Diagnostics Forecasted Market Size by Type (2022-2027)
5 Noninvasive Cancer Diagnostics Breakdown Data by Application
5.1 Global Noninvasive Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Noninvasive Cancer Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Noninvasive Cancer Diagnostics Market Size (2016-2027)
6.2 North America Noninvasive Cancer Diagnostics Market Size by Type
6.2.1 North America Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America Noninvasive Cancer Diagnostics Market Size by Application
6.3.1 North America Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America Noninvasive Cancer Diagnostics Market Size by Country
6.4.1 North America Noninvasive Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Noninvasive Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Noninvasive Cancer Diagnostics Market Size (2016-2027)
7.2 Europe Noninvasive Cancer Diagnostics Market Size by Type
7.2.1 Europe Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe Noninvasive Cancer Diagnostics Market Size by Application
7.3.1 Europe Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe Noninvasive Cancer Diagnostics Market Size by Country
7.4.1 Europe Noninvasive Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Noninvasive Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Noninvasive Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America Noninvasive Cancer Diagnostics Market Size by Type
9.2.1 Latin America Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Noninvasive Cancer Diagnostics Market Size by Application
9.3.1 Latin America Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Noninvasive Cancer Diagnostics Market Size by Country
9.4.1 Latin America Noninvasive Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Noninvasive Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Precision Therapeutics, Inc. (U.S.)
11.1.1 Precision Therapeutics, Inc. (U.S.) Company Details
11.1.2 Precision Therapeutics, Inc. (U.S.) Business Overview
11.1.3 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.1.4 Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.1.5 Precision Therapeutics, Inc. (U.S.) Recent Development
11.2 A&G Pharmaceutical, Inc. (U.S.)
11.2.1 A&G Pharmaceutical, Inc. (U.S.) Company Details
11.2.2 A&G Pharmaceutical, Inc. (U.S.) Business Overview
11.2.3 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.2.4 A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.2.5 A&G Pharmaceutical, Inc. (U.S.) Recent Development
11.3 Affymetrix Inc. (U.S.)
11.3.1 Affymetrix Inc. (U.S.) Company Details
11.3.2 Affymetrix Inc. (U.S.) Business Overview
11.3.3 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.3.4 Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.3.5 Affymetrix Inc. (U.S.) Recent Development
11.4 AVIVA Biosciences Corporation (U.S.)
11.4.1 AVIVA Biosciences Corporation (U.S.) Company Details
11.4.2 AVIVA Biosciences Corporation (U.S.) Business Overview
11.4.3 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
11.4.4 AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.4.5 AVIVA Biosciences Corporation (U.S.) Recent Development
11.5 BIOVIEW Inc. (U.S.)
11.5.1 BIOVIEW Inc. (U.S.) Company Details
11.5.2 BIOVIEW Inc. (U.S.) Business Overview
11.5.3 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.5.4 BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.5.5 BIOVIEW Inc. (U.S.) Recent Development
11.6 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
11.6.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
11.6.2 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
11.6.3 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Introduction
11.6.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.6.5 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Development
11.7 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
11.7.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
11.7.2 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
11.7.3 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.7.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.7.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Development
11.8 Digene Corporation (U.S.)
11.8.1 Digene Corporation (U.S.) Company Details
11.8.2 Digene Corporation (U.S.) Business Overview
11.8.3 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
11.8.4 Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.8.5 Digene Corporation (U.S.) Recent Development
11.9 Gen-Probe Incorporated (U.S.)
11.9.1 Gen-Probe Incorporated (U.S.) Company Details
11.9.2 Gen-Probe Incorporated (U.S.) Business Overview
11.9.3 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Introduction
11.9.4 Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.9.5 Gen-Probe Incorporated (U.S.) Recent Development
11.10 IVDiagnostics, Inc. (U.S.)
11.10.1 IVDiagnostics, Inc. (U.S.) Company Details
11.10.2 IVDiagnostics, Inc. (U.S.) Business Overview
11.10.3 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.10.4 IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.10.5 IVDiagnostics, Inc. (U.S.) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Clinical Chemistry
Table 3. Key Players of Immunochemistry/Immunoassay
Table 4. Key Players of Molecular Diagnostics
Table 5. Key Players of Others
Table 6. Global Noninvasive Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Noninvasive Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Noninvasive Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Noninvasive Cancer Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Noninvasive Cancer Diagnostics Market Share by Regions (2022-2027)
Table 12. Noninvasive Cancer Diagnostics Market Trends
Table 13. Noninvasive Cancer Diagnostics Market Drivers
Table 14. Noninvasive Cancer Diagnostics Market Challenges
Table 15. Noninvasive Cancer Diagnostics Market Restraints
Table 16. Global Noninvasive Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Noninvasive Cancer Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Noninvasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Noninvasive Cancer Diagnostics as of 2020)
Table 19. Ranking of Global Top Noninvasive Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Noninvasive Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Noninvasive Cancer Diagnostics Product Solution and Service
Table 23. Date of Enter into Noninvasive Cancer Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Noninvasive Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Noninvasive Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Noninvasive Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Noninvasive Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Noninvasive Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Noninvasive Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Noninvasive Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Noninvasive Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Noninvasive Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Precision Therapeutics, Inc. (U.S.) Company Details
Table 64. Precision Therapeutics, Inc. (U.S.) Business Overview
Table 65. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 66. Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Precision Therapeutics, Inc. (U.S.) Recent Development
Table 68. A&G Pharmaceutical, Inc. (U.S.) Company Details
Table 69. A&G Pharmaceutical, Inc. (U.S.) Business Overview
Table 70. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 71. A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 72. A&G Pharmaceutical, Inc. (U.S.) Recent Development
Table 73. Affymetrix Inc. (U.S.) Company Details
Table 74. Affymetrix Inc. (U.S.) Business Overview
Table 75. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 76. Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Affymetrix Inc. (U.S.) Recent Development
Table 78. AVIVA Biosciences Corporation (U.S.) Company Details
Table 79. AVIVA Biosciences Corporation (U.S.) Business Overview
Table 80. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Product
Table 81. AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 82. AVIVA Biosciences Corporation (U.S.) Recent Development
Table 83. BIOVIEW Inc. (U.S.) Company Details
Table 84. BIOVIEW Inc. (U.S.) Business Overview
Table 85. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 86. BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 87. BIOVIEW Inc. (U.S.) Recent Development
Table 88. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
Table 89. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
Table 90. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Product
Table 91. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Development
Table 93. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
Table 94. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
Table 95. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 96. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Development
Table 98. Digene Corporation (U.S.) Company Details
Table 99. Digene Corporation (U.S.) Business Overview
Table 100. Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Digene Corporation (U.S.) Recent Development
Table 102. Gen-Probe Incorporated (U.S.) Company Details
Table 103. Gen-Probe Incorporated (U.S.) Business Overview
Table 104. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Product
Table 105. Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Gen-Probe Incorporated (U.S.) Recent Development
Table 107. IVDiagnostics, Inc. (U.S.) Company Details
Table 108. IVDiagnostics, Inc. (U.S.) Business Overview
Table 109. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 110. IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 111. IVDiagnostics, Inc. (U.S.) Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Noninvasive Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Clinical Chemistry Features
Figure 3. Immunochemistry/Immunoassay Features
Figure 4. Molecular Diagnostics Features
Figure 5. Others Features
Figure 6. Global Noninvasive Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Solid Tumors Case Studies
Figure 8. Blood Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Noninvasive Cancer Diagnostics Report Years Considered
Figure 13. Global Noninvasive Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Noninvasive Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Noninvasive Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 16. Global Noninvasive Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 17. Global Noninvasive Cancer Diagnostics Market Share by Players in 2020
Figure 18. Global Top Noninvasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Noninvasive Cancer Diagnostics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Noninvasive Cancer Diagnostics Revenue in 2020
Figure 20. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 21. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 22. North America Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 24. North America Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 25. North America Noninvasive Cancer Diagnostics Market Share by Country (2016-2027)
Figure 26. United States Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 30. Europe Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 31. Europe Noninvasive Cancer Diagnostics Market Share by Country (2016-2027)
Figure 32. Germany Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Region (2016-2027)
Figure 42. China Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 50. Latin America Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 51. Latin America Noninvasive Cancer Diagnostics Market Share by Country (2016-2027)
Figure 52. Mexico Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Country (2016-2027)
Figure 58. Turkey Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Precision Therapeutics, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 62. A&G Pharmaceutical, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 63. Affymetrix Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 64. AVIVA Biosciences Corporation (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 65. BIOVIEW Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 66. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 67. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 68. Digene Corporation (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 69. Gen-Probe Incorporated (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 70. IVDiagnostics, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global and United States Pregnancy Test Meters Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 165
    Pregnancy Test Meters market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pregnancy Test Meters market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Pregn......
  • Global and Japan Medical Dressings Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 140
    Medical Dressings market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Dressings market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Medical Dressings mar......
  • Global and United States Trolley-mounted Physiotherapy Multifunctional Instruments Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 169
    Trolley-mounted Physiotherapy Multifunctional Instruments market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Trolley-mounted Physiotherapy Multifunctional Instruments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016......
  • Global and Japan Mobile Electrocardiograph Monitor Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 146
    Mobile Electrocardiograph Monitor market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Mobile Electrocardiograph Monitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focu......
  • Global and United States Painless Lancets Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 144
    Painless Lancets market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Painless Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Painless Lancet......
  • Global and United States Orthodontics Appliance Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 164
    Orthodontics Appliance market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Orthodontics Appliance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Ort......
  • Global and China Gynecological Care Training Manikins Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 125
    Gynecological Care Training Manikins market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gynecological Care Training Manikins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this repor......
  • Global and United States Rapid Pregnancy Testing Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 130
    Rapid Pregnancy Testing market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Rapid Pregnancy Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the R......
  • Global and Japan Self Testing Diagnostics Market Insights, Forecast to 2027
    Published: 22-Oct-2021        Price: US 3900 Onwards        Pages: 146
    Self Testing Diagnostics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Self Testing Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Self Te......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs